BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 3 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 4 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 5 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 3 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 4 days ago Synopsys Q1 2026 Earnings Results 4 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 4 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 4 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 5 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 3 hours ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 4 hours ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 5 hours ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 3 days ago Zoom Communications Q4 2025 Earnings Results 4 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 4 days ago Synopsys Q1 2026 Earnings Results 4 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 4 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 4 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 5 days ago
ADVERTISEMENT
Market News

Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results

Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance. Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last year Earnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the […]

$TMO October 23, 2024 1 min read
NYSE
$TMO · Earnings

Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance. Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last year Earnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the […]

· October 23, 2024

Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance.

  • Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last year
  • Earnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the year-ago quarter
  • On an adjusted basis, Q3 earnings dropped to $5.28 per share from $5.69 per share in the third quarter of 2023
  • Operating income for the third quarter was $1.84 billion, compared to $1.86 billion in the year-ago quarter
  • The company raised its full-year EPS guidance to the range of $21.35 to $22.07 from the previous guidance of $21.29 to $22.07
  • It continues to expect fiscal 2024 revenue to be between $42.4 billion and $43.3 billion
ADVERTISEMENT